India · Delayed Price · Currency is INR Shilpa Medicare Company Description
Shilpa Medicare Limited offers pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation (CDMO) services in India, the United States, Europe, and internationally.
The company offers various oncology and non-oncology APIs, such as anastrozole, acebrophylline, ambroxol hydrochloride, axitinib, azacitidine, abiraterone acetate, bendamustine HCL monohydrate, bicalutamide, bortezomib, busulphan, cabazitaxel amorphous, capecitabine, clofarabine, cyclophosphamide, dasatinib, decitabine, dimethyl fumarate, erlotinib HCL, enzalutamide, fingolimod hydrochloride, gemcitabine HCl, ibrutinib, imatinib mesylate, irinotecan HCl trihydrate, lenalidomide, lenvatinib mesylate, letrozole, and melphalan HCL.
It also provides nifedipine, oxaliplatin, pazopanib, pemetrexed disodium hemipentahydrate, pemetrexed dipotassium nonahydrate, pirfenidone, pomalidomide, sodium cholesteryl sulfate, sorafenib tosylate, sunitinib malate, temozolomide, teriflunomide, thalidomide, tranexamic and zoledronic acid, phenylephrine, citicholine, palbocicilib, nilotinib, nintedanib, praziquintol, carmustine, elthrombopag olamine, abacavir sulphate, tenofovir disproxyl fumarate API, tenofovir alfanamide, prucalopride succinate, and varenicline tartrate.
In addition, the company offers GLP-1; HpAPI; intermediates; peptides; payloads and linkers; biopolymers; microbial and mammalian products; fermentation; small molecules; monoclonal antibodies and recombinant technology; and tablets, capsules, injectables, oral dissolving films, and transdermal patches.
Further, it engages in wind power generation activities. The company serves wholesalers, distributors, doctors, pharmacy chain NGOs, hospitals, government institutions, and companies.
The company was formerly known as Shilpa Antibiotics Ltd and changed its name to Shilpa Medicare Limited in February 2003.
Shilpa Medicare Limited was incorporated in 1987 and is based in Raichur, India.
| Country | India |
| Founded | 1987 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,241 |
| CEO | Vishnukanth Bhutada |
Contact Details
Address: Shilpa House Raichur, Karnataka 584135 India | |
| Phone | 91 85 3223 8704 |
| Website | vbshilpa.com |
Stock Details
| Ticker Symbol | SHILPAMED |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE790G01031 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Vishnukanth Chaturbhuj Bhutada B. Pharm | MD and Director |
| Sharath Reddy Kalakota M.Pharma | Vice President of Projects and Operations and Whole-Time Director |
| Alpesh Maheshkumar Dalal | Chief Financial Officer |
| Monish Shah | Head of Investor Relations |
| Ritu Tiwary | Company Secretary and Compliance Officer |
| P. V. Narasimha Rao | Chief Human Resource Officer |
| Vinay Konaje | Business Head of Biologics |
| K. H. Honneshaiah | Head Operation of API |
| Rajeev Saxena | Senior Vice President ? Domestic Formulations and Biologics |
| Abhay Sapre | Senior Vice President of Formulation |